10 likes | 94 Vues
Cell Death (Ramos). Untreated. Proliferation (Ramos). hIgG (crosslinked). Dacetuzumab (soluble). Dacetuzumab (crosslinked). Percent Cell Death (apoptotic + necrotic). Crosslinking Ab. Dacetuzumab (soluble). hIgG (crosslinked). Dacetuzumab (crosslinked). CD40 Ligand.
E N D
Cell Death (Ramos) Untreated Proliferation (Ramos) hIgG (crosslinked) Dacetuzumab (soluble) Dacetuzumab (crosslinked) Percent Cell Death (apoptotic + necrotic) Crosslinking Ab Dacetuzumab (soluble) hIgG (crosslinked) Dacetuzumab (crosslinked) CD40 Ligand hIgG (soluble) Untreated mg/ml 1 3 10 1 3 10 10 10 20 1 ng/ml phospho-ERK1/2 MAPK Dacetuzumab (crosslinked) phospho-p38 MAPK IkB-a Dacetuzumab phospho-AKT Untreated 1.00x103 Lane: 1 2 3 4 5 6 7 8 9 10 11 4.12 12.3 37.0 111 333 ng/ml phospho-ERK1/2 MAPK b-Actin Ramos a Dacetuzumab Signaling (RL) b c Supplementary Figure 1 Lewis, et al.